News

In LEVEL UP period 2, most patients who switched from dupilumab to upadacitinib achieved higher skin clearance and itch relief by 16 weeks.

FDA declined approval of RGX-121 for MPS II, citing concerns about study design, control comparability, and surrogate endpoint validity.

Children who received early intervention services before the age of 3 years showed academic benefits in third-grade math and English language arts.

Children exposed to both household dampness and higher PM2.5 levels in early life face a significantly increased risk of developing asthma.

A new review highlights how rising childhood obesity, genetic susceptibility, and early-life gut microbiota changes contribute to youth-onset type 2 diabetes.

A study found that while nearly one-third of US youth used generative artificial intelligence apps, usage patterns varied widely by age, timing, and intensity.

Sophie Driker, MPH, and Anne CC Lee, MD, MPH, discuss the effectiveness of WHO IMCI clinical signs for detecting sepsis and mortality risk in infants younger than 60 days.

In this Q&A, Matthew Neidell, PhD, reviews new data finding no link between community water fluoridation and adverse birth outcomes.

Global meta-analysis identifies eczema, delayed allergen introduction, and early antibiotics as key food allergy risk factors.

A study found that combining remote and in-person delivery of a parenting program improved young children’s developmental outcomes and home environments.

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

A study found high rates of neurodevelopmental diagnoses and service use among children with congenital heart disease following infant heart surgery.

Phase 3 data show that high-dose I-ACQUIRE improved arm function at 6 months in infants and toddlers after perinatal stroke.

Findings from the ELSA study show that population-based screening using a simple dried blood spot test is highly feasible and well accepted by families.

FDA grants priority review to marstacimab for hemophilia A or B in children 6 years and older and patients with inhibitors.

A recent study found that nearly half of parents of children with high weight reported concerns about disordered eating.

FDA and partners are investigating a multistate infant botulism outbreak linked to powdered formula and assessing risks of Clostridium botulinum.

Giulia M. Muraca, PhD, MPH, and Maya Rajasingham, BSc, discuss new data comparing neurodevelopmental outcomes in children born via second-stage cesarean and assisted vaginal delivery.

A study shows how COVID-19 reshaped the circulation, seasonality, and coinfection patterns of respiratory viruses in children.

Experts urge culturally responsive nutrition counseling, noting the new Dietary Guidelines lack guidance on diverse food traditions and eating patterns.

Experts discuss access, affordability, and equity challenges in applying the new Dietary Guidelines, urging clinicians to reduce guilt and personalize care.

Experts debate stricter added sugar recommendations in the new Dietary Guidelines, stressing practicality, age-specific needs, and personalized counseling.

Experts flag missing pediatric guidance in the 2025–2030 Dietary Guidelines, including infant safety, iron intake, and early nutrition education.

Experts highlight gaps in the new Dietary Guidelines, including fiber, whole grains, plant-based milks, and simplified alcohol guidance.

Experts unpack saturated fat recommendations in the 2025–2030 Dietary Guidelines, highlighting visual misalignment and the need for personalized counseling.

Experts clarify protein recommendations in the 2025–2030 Dietary Guidelines, emphasizing quality, preparation, and clinician-led patient education.

Experts discuss whole-foods emphasis, microbiome insights, and consumer-focused changes in the 2025–2030 US Dietary Guidelines for clinicians.

Take a quick look at everything you may have missed this past month, including the top FDA approvals and latest clinical updates.